Publications

Articles:

2008

Pano-Pardo JR, Alcaide M, Abbo L, Dickinson G. Primary HIV infection with multisystemic presentation. Int J Infect Dis. 2008 Nov 21. [epub ahead of print]

Alcaide M, Abbo L, Pano JR, Gaynor JJ, Tryphonopolous P, Weppler D, Moon J, Tzakis AG, Morris M. Herpes zoster infection after liver transplantation in patients receiving induction therapy with alemtuzumab. Clin Transplant. 2008 Jul-Aug;22(4):502-7. Epub 2008 Jul 8.

Arribas JR, Pozniak AL, Gallant JE, Dejesus E, Gazzard B, Campo RE, et al. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis. J Acquir Immune Defic Syndr. 2008;47:74-8.

Castro J, Baldarrago G, Moneda A and Patton I. Papanicolaou test in an urban STD clinic: the good and bad news. Florida Public Health Review. 2008 Jun 30;5:60-63.

Cohen CJ, Berger DS, Blick G, Grossman HA, Jayaweera DT, et al. Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial. AIDS. 2008 Dec 24. Epub ahead of print.

Jayaweera DT, Espinoza L, Castro J. Etravirine: the renaissance of non-nucleoside reverse transcriptase inhibitors. Expert Opin Pharmacother. 2008;9(17):3083-94.

Baum MK, Jayaweera DT, Duan R, Sales S, Lai S, et al. Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. J Addict Dis.  2008;27(2):37-48.

Waldrop-Valverde D, Jones DL, Jayaweera DT, Gonzalez P, Romero J, Ownby RL. Gender differences in medication management capacity in HIV infection: The role of health literacy and numeracy. AIDS Behav. 2009 Feb;13(1):46-52. Epub 2008 Jul 10.

Baum MK, Rafie C, Sales S, Lai S, Duan R, Jayaweera DT, et al. C-reactive protein: a poor marker of cardiovascular disease risk in HIVþ populations with high prevalence of elevated serum transaminases. Int J STD AIDS. 2008 Jun;19(6):410-3.

Boyle BA, Jayaweera DT, Witt MD, et al. Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression. HIV Clin Trials. 2008 May-Jun;9(3):164-76. 

Kolber MA. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1 infected individuals. AIDS. 2008;22:1937-41.

Strbo N, de Armas L, Liu H, Kolber MA, Lichtenheld M and Pahwa S.  IL-21 augments NK effector functions in chronically HIV-infected individuals, AIDS. 2008;22:1551-60.

Kolber MA, Saenz MO, Tanner TJ, Arheart KL, Liu H, Pahwa S. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation. Clin Immunol. 2008;126:315-21.

Garrison AP, Procop GW, Vincek V, Moon J, Morris MI, Doblecki Lewis S, Cleary TJ, Brust D, Rosa-Cunha I.  A case of subcutaneous Mycoleptodiscus indicus  infection in a liver transplant recipient successfully treated with antifungal therapy. Transpl Infect Dis. 2008;10:218-220.

2007

Abbo L, Vincek V, Dickinson G, Shrestha N, Doblecki S, Haslett PA. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod. Clin Infect Dis. 2007 Feb 1;44(3):e25-7. Epub 2006 Dec 29.

Abbo L, Alcaide ML, Pano JR, Robinson PG, Campo RE.  Fulminant hepatitis from herpes simplex virus type 2 in an immunocompetent adult. Transpl Infect Dis. 2007 Dec;9(4):323-6. Epub 2007 Jul 1.

Alcaide M, Bisno A. Pharyngitis and epiglottitis. Infect Dis Clin North Am. 2007 Sep;21(3):449-69.

Simkins J, Alcaide M, Pano JR, Trillo C, Symes S, Baracco G. Cryptococcal meningitis in a patient with liver cirrhosis. Case report and review of the literature. Infect Med. 2007 Aug:29-32.

Corrales-Medina V, Concha R, Simkins J, Sanchez M, Baracco G. Native valve endocarditis caused by rapidly growing mycobacteria. Case report and review of the literature. Scand J Infect Dis. 2007;39(6):639-41.

Hallal A, Cohn SM, Namias N, Habib F, Baracco GJ, Manning RJ, Crookes B, Schulman CI. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect. 2007; 8 (1): 73-82.

Campo RE, Narayanan S, Clay PG, Dehovitz J, et al. Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients. AIDS Patient Care STDs. 2007;21:329-38.

Castro J, Gutierrez R, Villena J. Update in the treatment of HIV infection for the general practitioner. Acta Medica Peruana. 2007;24(3):208-222. 

Casula S, Castro JG, Espinoza LA. An unusual case of mastoiditis evolved into multiple ring-enhancing intracerebral lesions in a person with HIV infection. AIDS Read. 2007 Aug;17(8):402-4.

Castro J, Manzi, G, Espinoza L, Campos M, Boulanger C. Concurrent PCP and TB Pneumonia in HIV infected patients. Scand J Infect Dis. 2007;39(11-12):1054-8. Epub 2007 Jun 21.

Castro J, Scerpella E, Espinoza L. Severe anemia in hospitalized HIV positive adult in the Jackson Memorial Hospital. [Sp] Acta Med Per 2007; 24(1):15-17.

Doblecki-Lewis S, Palaios E, Bejarano P, Tzakis A, Selvaggi G, Morris MI. Hepatic gas gangrene following orthotopic liver transplantation: three cases treated with retransplantation and a review of the literature. Transpl Infect Dis. 2008 Jul;10(4):280-5. Epub 2007 Dec 7.

Miguez-Burbano MJ, Espinoza L, Lewis JE. HIV treatment adherence and sexual functioning. AIDS Behav. 2008 Jan;12(1):78-85. Epub 2007 Feb 13.

Schreibman I, Gaynor JJ, Jayaweera DT, Pyrsopoulos N, Weppler D. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation. 2007;84: 697–705.

Clotet B, Bellos N, Molina JM, Cooper D, Goffard JC, Lazzarin A, Wöhrmann A, Katlama C, Wilkin T, Haubrich R, Cohen C, Farthing C, Jayaweera DT, et al. on behalf of the POWER 1 and 2 study groups. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomized trials. The Lancet. 2007 Apr 7;369(9568):1169-78.

TMC125-C223 Writing Group. Nadler JP, Berger DS, Blick G, Cimoch PJ, Cohen CJ, Greenberg RN, Hicks CB, Hoetelmans RM, Iveson KJ, Jayaweera DT, et al. Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.  AIDS. 2007 Mar 30;21(6):F1-10.

Campa A, Jayaweera DT, Raffia C, Sales S, et al. WHEN “When Access to  Antiretroviral Treatment for all is not enough. Journal of Public Administration and Management, 2007;12(3):147-159.Kolber MA, Saenz MO, Tanner TJ, Arheart KL, Pahwa S, Liu H. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation. Clin Immunol. 2008 Mar;126(3):315-21. Epub 2007 Nov 9.

Kolber MA. Development of drug resistance mutations in patients on highly active antiretroviral therapy: Does competitive advantage drive evolution, AIDS Reviews (invited). 2007;9:68-74.

Kolber MA, Saenz MO, Gomez-Marin O, Tamariz LJ. Race and ethnicity impact on the maximum proliferative response in PBL from sero-positive individuals. HIV Med. 2007:8;401-5.

White L, Krisham S, Strbo N, Liu H, Kolber MA, Lichtenheld MG, Pahwa S.  Differential effect of IL-21 and IL-15 on perforin expression, lysosomal degranulation and proliferation in CD8 cells of patients infected with Human Immunodeficiency Virus-1 (HIV). Blood. 2007;109:3873-8.

Rodriguez AE, Metsch LR, Saint-Jean G, Molina E, Kolber M. Differences in HIV-related hospitalization trends between Haitians and US-born blacks. JAIDS. 2007;45:529-34.

Simkins J, Corrales-Medina V, Symes S, Dickinson G. Pulmonary embolism in patients with acquired immunodeficiency syndrome presenting with clinical picture of Pneumocystis jiroveci pneumonia: report of two cases. Scand J Infect Dis. 2007;39(6-7):634-6.

2006

Chirinos JA, Garcia J, Alcaide ML, Toledo G, Baracco GJ, Lichtstein DM. Septic thrombophlebitis: diagnosis and management. Am J Cardiovasc Drugs. 2006;6(1):9-14. Review.

Pozniak AL, Gallant JE, Dejesus E, Arribas JR, Gazzard B, Campo RE, et al; for the Study 934 Group.  Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: virologic, immunologic, and morphologic changes: A 96-week analysis. J Acquir Immune Defic Syndr. 2006;43:535-40.

Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, et al.; for the Study 934 Group. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.  N Engl J Med 2006; 354:251-60.

Castro JG, Espinoza L. Nocardia species infections in a large county hospital in Miami: 6 years experience. J Infect. 2007 April;54(4):358-61. Epub 2006 Sep 18.

Gathe J, Cooper DA, Farthing C, Jayaweera DT, et al. Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-Week analysis from the RESIST-1 Trial. Clin Infect Dis.  2006;43:1337-46. Epub 2006 Oct 17.

Montaner JS, Schutz M, Schwartz R, Jayaweera DT et al. Efficacy, safety and pharmacokinetics of once-daily saquinavir soft-gelatin capsule/ritonavir in antiretroviral-naive, HIV-infected patients. Med Gen Med. 2006 May 10;8(2):36.

Neff GW, Jayaweera DT, Sherman K. Drug induced liver injury in HIV patients. Gastroenterology and Hepatology. 2006;2(6):430-7.

Morris M, Villmann M. Echinocandins in the management of invasive fungal infections, Part 1.  Am J Health-Syst Pharm. Sep 15, 2006;53:1693-1703.

Morris M, Villmann M. Echinocandins in the management of invasive fungal infections, Part 2.  Am J Health-Syst Pharm. Oct 1, 2006; 63:1813-1820.

Corrales-Medina V, Symes S, Valdivia-Arenas M, Boulanger C. Localized Mycobacterium avium complex infection of vertebral and paravertebral structures in an HIV patient on highly active antiretroviral therapy. South Med J. 2006 Feb;99(2):174-7.

2005

Baracco GJ, Cooper EM. Racemose neurocysticercosis. Infections in Medicine 2005;22:239-241.

Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Alhaddad A, Lasko D, Amortegui J, Dy CJ, Dlugasch L, Baracco G, Cohn SM. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surgical Infections. 2005;6(4): 369-375.

Servin-Abad L, Molina E, Baracco GJ, Arosemena L, Regev A, Jeffers L, Schiff E. Liver enzymes elevation after HAART in HIV-HCV co-infection. Journal of Viral Hepatitis, 2005;12:429-434.

Campo RE, Lalanne R, Tanner TJ, Jayaweera DT, Rodriguez AE, Fontaine L, Kolber MA . Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.  AIDS. 2005;19(4):447-9.

Campo RE , Alvarez D, Santos G, Latorre J. Antiretroviral treatment considerations in Latino patients. AIDS Patient Care and STDs. 2005;19:366-74.

Campo RE, Campo CE, Peter G, Zuleta J, Wahlay NA, Cleary T, Kolber MA, Dickinson GM. Differences in presentation and outcome of invasive pneumococcal disease among patients with and without HIV infection in the pre-HAART era. AIDS Patient Care and STDs. 2005;19:141-9.

Zagvazdina IA, Zagvazdin Y, Willis GE, Gonzalez JH, Lesser W, Dickinson G. Rare infections are just an airplane trip away: Salmonella typhi meningitis in a recent immigrant to the United States. Am J Med Sci. 2005 Oct;330(4):198-200.

Dragsted UB, Gerstoft J, Youle M, Fox Z, Losso M, Benetucci J, Jayaweera DT, et al. for the MaxCmin2 trial group. A randomized trial to evaluate the efficacy and safety of lopinavir/ritonavir versus saquinavir/ritonavir in adult HIV-1 infected patients: the MaxCmin2 Trial. Antivir Ther. 2005;10(6):735-43.
 
Jayaweera DT.  Tipranavir: A ritonavir-boosted protease inhibitor: a viewpoint. Drugs. 2005;65(12):1678-9.

Kolber MA , Saenz MO, Kaul S. Memory responses in human immunodeficiency virus type 1-infected individuals with long-term viral load suppression are independent of CD4 cell nadir. Clin Diagn Lab Immunol. 2005 Jan;12(1):76-80.

Kolber MA. A K103N resistance mutation is not an absolute contraindication to adding efavirenz to a salvage regimen: a case report. AIDS. 2005 Aug 12;19(12):1337-8.

Keiser PH, Sension MG, DeJesus E, Rodriguez A, et al.  the ESS40003 Study Team. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment. BMC Infectious Diseases. 2005;5:2.

2004

Alcaide ML, Espinoza L, Abbo L. Cavitary pneumonia secondary to Tsukamurella in an AIDS patient: first case and review of the literature. J Infect. 2004 Jul;49(1):17-9.

Alcaide M, Lichtstein D. Management of urinary tract infections in patients with urinary catheters. Hosp Physician. 2004;40:29-33.

Alcaide M, Lichtstein D. How best to treat urinary tract infections. A rational approach. Consultant 2004;44:1145-51.

Sureka A, Parada JP, Deloria-Knoll M, Chmiel JS, Phan L, Lyons TM, Ali S, Yarnold PR, Weinstein RA, Dehovitz JA, Jacobson JM, Goetz MB, Campo RE, et al. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDs. 2004 Feb;18(2):99-107.

Chung M, Dickinson G, De Lencastre H, Tomasz A. International clones of methicillin-resistant Staphylococcus aureus in two hospitals in Miami, Florida. J Clin Microbiol. 2004 Feb;42(2):542-7.

Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM Jr, LaLota M, Dickinson G, et al. The epidemiology of antiretroviral drug resistance among drug-naïve HIV-1-infected persons in 10 US cities. J Infect Dis. 2004 Jun 15;189(12):2174-80. Epub 2004 May 21.

Metsch LR, Pereyra M, del Rio C, Gardner L, Duffus WA, Dickinson G, et al. for the Antiretroviral Treatment and Access Study Group. Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 U.S. cities. Am J Public Health. 2004. Jul;94(7):1186-92.

Jayaweera DT, Kolber MA , Brill M, Tanner T, Campo R, Rodriguez A, Chu HM, Garg V. Efficacy  and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naive patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy. HIV Med. 2004 Sep;5(5):364-70.

Kolber MA. Impact of immune plasticity on development of cellular memory responses to human immunodeficiency virus type 1. Clin Diagn Lab Immunol. 2004 Nov;11(6):1002-7.

Kolber MA, Campo RE, Dickinson GM. Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable? IUBMB Life. 2004 Jun;56(6):301-7.

Rodriguez AE, Campo RE, Gathe JC Jr, Kwakwa HA. Impact of resistance to antiretroviral therapy in the minority community. AIDS Read. 2004 Oct;14(10 Suppl):S9-11.

De Toledo FG, Symes SN. Leukemoid reaction due to Clostridium dificile infection in acquired immunodeficiency syndrome: two case reports and a review of the literature. South Med J. 2004 Apr;97(4):388-92.

Goodkin K, Shapshak P, Asthana D, Zheng W, Concha M, Wilkie FL, Molina R, Lee D, Suarez P, Symes S, Khamis I. Older age and plasma viral load in HIV-1 infection. AIDS. 2004 Jan 1;18 Suppl 1:S87-98.

2003

Alcaide ML, Jayaweera DT, Espinoza L, Kolber M. Wernicke’s encephalopathy in AIDS: a preventable cause of fatal neurological deficit. Int Jourf STD AIDS. 2003 Oct;14(10):712-3.

Parada JP, Deloria-Knoll M, Chmiel JS, Arozullah AM, Phan L, Ali SN, Goetz MB, Weinstein RA, Campo R, et al. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. 2003 Dec 1;37(11):1549-55. Epub 2003 Nov 06.

Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, et al. Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1). J Environ Pathol Toxicol Oncol. 2003;22(3):201-34.

Patarca R, Isava A, Campo R, Rodriguez NJ, Nunez E, Alter M, Marchette M, Sanabia MM, Mitchell C, Rivera D, Scott G, Jayaweera D, Moreno J, Boulanger C, Kolber M, et al. Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2). J Environ Pathol Toxicol Oncol. 2003;22(4):235-79.

Campo RE, Rosa I, Lichtenberger PN, Suarez G, Rivera FA, Jayaweera DT, Rodriguez AE, Wahlay NA, Kolber MA. Effect of class-specific therapy interruption on persistence of HIV type 1 antiretroviral resistance. AIDS Res Hum Retroviruses. 2003 Aug;19(8):653-6.

Campo RE, Moreno JN, Suarez G, Miller N, Kolber MA, Holder DJ, Shivaprakash M, DeAngelis DM, Wright JL, Schleif WA, Emini EA, Condra JH. Efficacy of indinavir-ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures. AIDS. 2003 Sep 5;17(13):1933-9.

Campo RE, Lichtenberger PN, Rosa I, Suarez G, Rivera FA, Rodriguez AE, Jayaweera DT, Wahlay NA, Kolber MA. Differences in the frequency of resistance to antiretroviral drug classes among human immunodeficiency virus type 1 clinical isolates. J Clin Microbiol. 2003 Jul;41(7):3376-8.

Duffus WA , Barragan M, Metsch L, Krawczyk CS, Loughlin AM, Gardner LI, Anderson-Mahoney P, Dickinson G, del Rio C for the Antiretroviral Treatment and Access Studies Study Group. Effect of physician specialty on counseling practices and medical referral patterns among physicians caring for disadvantaged human immunodeficiency virus-infected populations. Clin Infect Dis. 2003 Jun 15;36(12):1577-84. Epub 2003 Jun 05.

Santos E, Baldarrago G, Espinoza, L, Chaparro A, et al. Primary non-Hodgkin’s lymphomas (NHL) of the oral cavity in patients with diagnosis of Human Immunodeficiency Virus (HIV) infection. Blood. Nov 16, 2003; Vol 102(11)Sup 2:280b (4843a).

Neff G, Schiff E, Fung J, Ragni M, Jayaweera D. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transplantation. March 2003;9(3):239-47.

Jayaweera DT, Scerpella E, Robinson M, Rode R, Campo RE, Rodriguez A, Lalane R, Tanner T, Kolber MA. The safety and efficacy of a 2-drug regimen of indinavir and ritonavir (400 mg/400 mg BID) in HIV-infected individuals from an inner-city minority population. A pilot study. Int J STD AIDS. 2003 Nov;14(11):732-6.

Kolber MA, Saenz MO. Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals. Clin Diagn Lab Immunol. 2003 Sep;10(5):757-63.
Daikos GL, Cleary T , Rodriguez A , Fischl MA. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis. 2003 Apr;7(4):394-98.

Wilkie FL , Goodkin K, Khamis I, van Zuilen MH, Lee D, Lecusay R, Concha M, Symes S, et al. Cognitive functioning in younger and older HIV-1-infected adults. J Acquir Immune Defic Syndr. 2003 Jun 1;33 Suppl 2:S93-S105.

2002

Alcaide ML, Kolber M, Jayaweera DT. Would switching the protease inhibitors (PI) to tenofovir be an option in controlling hypertriglyceridemia secondary to PIs? A case report. Int. J of STD and AIDS. 2002 Nov 13(11):795-6.
Dowdy L, Castro J, Duchesne C, Cleary T. Necrotizing fasciitis from Apophysomyces elegans infection following trauma. Infections in Medicine. 2002;19(6):286-289. 

Castro J and Gutierrez L. Rhabdomyolisis with acute renal failure probably related to the interaction of atorvastatin and  delavirdine. The American Journal of Medicine. 2002; 112(6):505.

Chirgwin K, Hafner R, Leport C, Ramington J, Anderson J, Bosler EM, Roque C, Jayaweera DT, et al . Randomized phase 11 trial of Atovoquane with pyrimethamine or sulfadiazine for the treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 study AIDS Clinical Trials Group. Clin Infect Dis. 2002 May 1;34(9):1234-50.

Neff GW, Jayaweera D, Tzakis A.  Liver Transplantation for HIV-infected patients with end stage liver disease.  Current Opinion in Organ Transplantation. 2002;7(2):114-123.

Kolber MA, Gabr AH, De La Rosa I, Glock JA, Jayaweera DT, Miller N, Dickinson GM. Genotypic analysis of plasma HIV-1 RNA after influenza vaccination of patients with previously undetectable viral loads. AIDS. 2002 Mar 8;16:537-48.

2001

Baracco GJ, Dickinson GM. Pulmonary Nocardiosis. Curr Infect Dis Rep. 2001 Jun;3(3):286-292.
Kim B, Lyons TM, Parada JP, Uphold CR, Yarnold PR, Hounshell JB, Sipler AM, Goetz MB, DeHovitz JA, Weinstein RA, Campo RE, Bennett CL. HIV-associated Pneumocystis carinii pneumonia in older patients hospitalized in 1995-1997. J Gen Intern Med. 2001;16:583-9.

Patarca R, Isava A, Campo R, Rodriguez N, Jayaweera DT, et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Pharmacogenomic in Clinical Practice:  Relevance of HIV-1 Drug Resistance Testing.  Critical Reviews in Oncogenesis 2001;12(1):47-106.

Castro J. Occurrence of acute hepatitis A in patients infected with Human Immunodeficiency Virus. Clinical Infectious Diseases  2001; 33(9): 1613.

Rabeneck L, Menke T, Simberkoff MS, Hartigan PM, Dickinson GM, et al. Using the national registry of HIV-infected veterans in research: lessons for the development of disease registries. J Clin Epidemiol. 2001 Dec;54(12):1195-203.

Jacobson JM, Hafner R, Jayaweera DT. Remington J. et al. Dose escalation, Phase 1/11 study of azithromycin and pyremethmine for the treatment of toxoplasmic encephalitis in AIDS. AIDS. 2001 Mar 30;15:583-9.

Kolber MA, Saenz MO. Enhancement of antigen driven lymphocyte proliferation secondary to GP41-induced B7 expression on adherent monocytes. Cell Immunol. 2001 Nov 25;214(1):35-44.

Goodkin K, Wilkie FL, Concha M, Hinkin CH, Symes S, et al. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin Epidemiol. 2001 Dec;54 Suppl 1:S35-43.

2000

Osiyemi O, Dickinson G. Gram-Positive Pneumonia. Curr Infect Dis Rep. 2000 Jun;2(3):207-214.

Cheung TW, Jayaweera DT, Pearce D. et al., Safety of oral versus intravenous hydration during induction therapy with intravenous forscarnet in AIDS patients with cytomegalovirus infection. Int. J of STD and AIDS. 2000;11;640-647.

1999

Baracco GJ, Bisno AL. Therapeutic approaches to streptococcal toxic shock syndrome. Curr Infect Dis Rep. 1999 Aug;1(3):230-237.

Castro J, Dowdy L. Septic shock caused by Staphylococcus lugdunensis. Clinical Infectious Diseases 1999;28:681-2.
Maher K, Klimas N, Fletcher MA, Cohen V, Maggio CM, Triplett J, Valenzuela R, Dickinson G. Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center. J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):358-63.

Palmer CJ, Dubon JM, Koenig E, Perez E, Ager A, Jayaweera DT, et al. Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol. 1999 Nov;37(11):3698-700.

Ashok V, Roland S, Jayaweera DT, et al. Fulminant axonal neuropathy with lactic acidosis and hyperglycemia associated with nucleoside analog therepy in an HIV patient. Case report. Neurology. 1999;53:1365-7.

Raez L, Cabral L, Cai J, Landy H, Sfakianakis G, Byrne G, Hurley J, Scerpella E, Jayaweera D, Harrington W. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin-2. AIDS Res Hum Retroviruses. 1999;15(8):713-719.

Rodriguez A, Dickinson G. Case of acne fulminans associated with splenomegaly and panniculitis. Infectious Diseases in Clinical Practice. 1999;8(9):461-464.

Books, Book Chapters:

Chan JC, Campo RE.  HIV Infection. In: Tan, JS, File TM Jr., Salata RA, Tan MJ, eds.  Expert Guide to Infectious Diseases, 2nd ed.  Philadelphia: ACP Press; 2008:723-759.

Baracco GJ, Bisno AL. Group C and Group G Streptococcal Infections: Epidemiologic and Clinical Aspects. In: Fischetti et al. eds. Gram-positive Pathogens. 2nd ed.  Washington, DC: ASM Press; 2006.

Espinoza, L. Pneumocystis pneumonia (PCP). In: Beal J, Orrick JJ, Alfonso K, Rathore M, eds. HIV/AIDS Primary Care Guide. Williston, VT: Crown House Publishing Company; 2006: chap 22:355-358.

Espinoza, L. Toxoplasmosis. In: Beal J, Orrick JJ, Alfonso K, Rathore M, eds. HIV/AIDS Primary Care Guide. Williston, VT: Crown House Publishing Company; 2006: chap 23:359-363.

Morris MI, Fishman JE. Pulmonary Infections in the immunocompromised host.  In: McAdams HP, Reddy GP, eds. Cardiopulmonary Imaging: Categorical Course Syllabus. American Roentgen Ray Society. 2005:85-104.

Bisno AL, Campo RE, Collins CM.  M proteins of group G streptococci: structural and functional studies. Totolian A, ed. Pathogenic Streptococci: Present and Future. St. Petersburg: Lancer Publications; 1994: 225-227.

Campo RE, Bisno AL. Streptococcal infections. In: 1994 Medical and Health Annual. Chicago: Encyclopedia Britannica, Inc.; 1993:425-430.